Press

If you are a member of the media and wish to speak to a representative of the ACLU of Illinois, please call 312-201-9740 or email media@aclu-il.org. If you are a member of the media and wish to receive ACLU of Illinois press releases, please send your name, the outlet for which you work, your email address, and phone number to media@aclu-il.org with the subject line “Press Release Distribution.”

Filter Press

ACLU of Illinois Responds to Passage of House Bill 1596

Illinois Legislature passed HB1596, a measure which amends various child welfare and juvenile court statutes to reflect more inclusive language in laws relating to children and families.

May 4, 2023

ACLU of Illinois Responds to Passage by Danville City Council of Ordinance that Violates State Law and Constitution

The Danville City Council voted to approve an ordinance that would declare the community a “sanctuary city for the unborn” and attempt to place limits on abortion care in the community.

May 2, 2023

ACLU of Illinois Warns Danville that Proposed Ordinance Violates State Law and Constitution

The ACLU of Illinois sent a letter to Danville warning that a proposed ordinance that would declare the community a “sanctuary city for the unborn” is illegal under the Illinois Constitution and Illinois law

April 25, 2023

ACLU of Illinois Responds to Supreme Court’s Stay of Mifepristone Suspension

SCOTUS granted a request by Department of Justice and manufacturers of Mifepristone to stay the decision that severely restricted access to the widely used medication.

April 21, 2023

ACLU of Illinois Responds to Federal Appellate Court’s Block of Ban on Mifepristone

Overnight, a panel of judges on the Fifth Circuit Court of Appeals partially blocked enforcement of last week's ruling suspending the FDA's approval of mifepristone.

April 13, 2023

ACLU of Illinois Responds to Decision by Texas Court on Availability of Mifepristone

A Texas judge issued a legally and factually indefensible ruling that seeks to block the Federal Drug Administration’s approval of mifepristone from more than two decades ago.

April 7, 2023